APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Cancer

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Kidney Cancer Industry Growth and Trends Forecast to 2032

31 December 2025102 pages

Choose your research edition.

Industry ResearchKidney Cancer Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Cancer Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Kidney Cancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Cancer Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Cancer Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Kidney Cancer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Kidney Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Kidney Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kidney Cancer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kidney Cancer include Eisai, Novartis, Merck, Roche, Pfizer, Bayer, Amgen, Sun Pharmaceutical and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Kidney Cancer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Kidney Cancer market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kidney Cancer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kidney Cancer.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Kidney Cancer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Kidney Cancer Market by Company

Eisai

Novartis

Merck

Roche

Pfizer

Bayer

Amgen

Sun Pharmaceutical

Hikma Pharmaceuticals

Exelixis

Bristol-Myers Squibb

Aveo Pharmaceuticals

Kidney Cancer Segment by Type

Targeted Therapy

Immunotherapy

Surgery

Other

Kidney Cancer Segment by Application

肾细胞癌（RCC）

移行细胞癌（TCC）

Kidney Cancer Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Cancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Cancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Cancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kidney Cancer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Kidney Cancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Targeted Therapy Table 2. Major Company of Immunotherapy Table 3. Major Company of Surgery Table 4. Major Company of Other Table 5. Global Kidney Cancer Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Kidney Cancer Sales by Type (2021-2026) & (K Units) Table 7. Global Kidney Cancer Sales Market Share in Volume by Type (2021-2026) Table 8. Global Kidney Cancer Sales by Type (2021-2026) & (US$ Million) Table 9. Global Kidney Cancer Sales Market Share in Value by Type (2021-2026) Table 10. Global Kidney Cancer Price by Type (2021-2026) & (US$/Unit) Table 11. Global Kidney Cancer Sales by Type (2027-2032) & (K Units) Table 12. Global Kidney Cancer Sales Market Share in Volume by Type (2027-2032) Table 13. Global Kidney Cancer Sales by Type (2027-2032) & (US$ Million) Table 14. Global Kidney Cancer Sales Market Share in Value by Type (2027-2032) Table 15. Global Kidney Cancer Price by Type (2027-2032) & (US$/Unit) Table 16. North America Kidney Cancer Sales by Type (2021-2026) & (K Units) Table 17. North America Kidney Cancer Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Kidney Cancer Sales by Type (2021-2026) & (K Units) Table 19. Europe Kidney Cancer Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Kidney Cancer Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Kidney Cancer Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Kidney Cancer Sales by Type (2021-2026) & (K Units) Table 23. Latin America Kidney Cancer Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Kidney Cancer Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Kidney Cancer Sales by Type (2021-2026) & (US$ Million) Table 26. Kidney Cancer Industry Trends Table 27. Kidney Cancer Industry Drivers Table 28. Kidney Cancer Industry Opportunities and Challenges Table 29. Kidney Cancer Industry Restraints Table 30. Global Kidney Cancer Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Kidney Cancer Revenue Market Share by Company (2021-2026) Table 32. Global Kidney Cancer Sales by Company (2021-2026) & (K Units) Table 33. Global Kidney Cancer Sales Share by Company (2021-2026) Table 34. Global Kidney Cancer Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Kidney Cancer Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Kidney Cancer Major Company Production Sites and Headquarters Table 37. Global Kidney Cancer Company, Product Type & Application Table 38. Global Kidney Cancer Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Kidney Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Kidney Cancer Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Kidney Cancer Sales by Region (2021-2026) & (K Units) Table 43. Global Kidney Cancer Sales Market Share in Volume by Region (2021-2026) Table 44. Global Kidney Cancer Sales by Region (2021-2026) & (US$ Million) Table 45. Global Kidney Cancer Sales Market Share in Value by Region (2021-2026) Table 46. Global Kidney Cancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Kidney Cancer Sales by Region (2027-2032) & (K Units) Table 48. Global Kidney Cancer Sales Market Share in Volume by Region (2027-2032) Table 49. Global Kidney Cancer Sales by Region (2027-2032) & (US$ Million) Table 50. Global Kidney Cancer Sales Market Share in Value by Region (2027-2032) Table 51. Global Kidney Cancer Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Kidney Cancer Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Kidney Cancer Sales by Application (2021-2026) & (K Units) Table 54. Global Kidney Cancer Sales Market Share in Volume by Application (2021-2026) Table 55. Global Kidney Cancer Sales by Application (2021-2026) & (US$ Million) Table 56. Global Kidney Cancer Sales Market Share in Value by Application (2021-2026) Table 57. Global Kidney Cancer Price by Application (2021-2026) & (US$/Unit) Table 58. Global Kidney Cancer Sales by Application (2027-2032) & (K Units) Table 59. Global Kidney Cancer Sales Market Share in Volume by Application (2027-2032) Table 60. Global Kidney Cancer Sales by Application (2027-2032) & (US$ Million) Table 61. Global Kidney Cancer Sales Market Share in Value by Application (2027-2032) Table 62. Global Kidney Cancer Price by Application (2027-2032) & (US$/Unit) Table 63. North America Kidney Cancer Sales by Application (2021-2026) & (K Units) Table 64. North America Kidney Cancer Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Kidney Cancer Sales by Application (2021-2026) & (K Units) Table 66. Europe Kidney Cancer Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Kidney Cancer Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Kidney Cancer Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Kidney Cancer Sales by Application (2021-2026) & (K Units) Table 70. Latin America Kidney Cancer Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Kidney Cancer Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Kidney Cancer Sales by Application (2021-2026) & (US$ Million) Table 73. Eisai Company Information Table 74. Eisai Business Overview Table 75. Eisai Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Eisai Kidney Cancer Product Portfolio Table 77. Eisai Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis Kidney Cancer Product Portfolio Table 82. Novartis Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Kidney Cancer Product Portfolio Table 87. Merck Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Roche Kidney Cancer Product Portfolio Table 92. Roche Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Pfizer Kidney Cancer Product Portfolio Table 97. Pfizer Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Bayer Kidney Cancer Product Portfolio Table 102. Bayer Recent Development Table 103. Amgen Company Information Table 104. Amgen Business Overview Table 105. Amgen Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Amgen Kidney Cancer Product Portfolio Table 107. Amgen Recent Development Table 108. Sun Pharmaceutical Company Information Table 109. Sun Pharmaceutical Business Overview Table 110. Sun Pharmaceutical Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sun Pharmaceutical Kidney Cancer Product Portfolio Table 112. Sun Pharmaceutical Recent Development Table 113. Hikma Pharmaceuticals Company Information Table 114. Hikma Pharmaceuticals Business Overview Table 115. Hikma Pharmaceuticals Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Hikma Pharmaceuticals Kidney Cancer Product Portfolio Table 117. Hikma Pharmaceuticals Recent Development Table 118. Exelixis Company Information Table 119. Exelixis Business Overview Table 120. Exelixis Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Exelixis Kidney Cancer Product Portfolio Table 122. Exelixis Recent Development Table 123. Bristol-Myers Squibb Company Information Table 124. Bristol-Myers Squibb Business Overview Table 125. Bristol-Myers Squibb Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Bristol-Myers Squibb Kidney Cancer Product Portfolio Table 127. Bristol-Myers Squibb Recent Development Table 128. Aveo Pharmaceuticals Company Information Table 129. Aveo Pharmaceuticals Business Overview Table 130. Aveo Pharmaceuticals Kidney Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Aveo Pharmaceuticals Kidney Cancer Product Portfolio Table 132. Aveo Pharmaceuticals Recent Development Table 133. North America Kidney Cancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America Kidney Cancer Sales by Country (2021-2026) & (K Units) Table 135. North America Kidney Cancer Sales Market Share by Country (2021-2026) Table 136. North America Kidney Cancer Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America Kidney Cancer Sales Market Share Forecast by Country (2027-2032) Table 138. North America Kidney Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Kidney Cancer Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Kidney Cancer Market Share by Country (2021-2026) Table 141. North America Kidney Cancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Kidney Cancer Market Share Forecast by Country (2027-2032) Table 143. Europe Kidney Cancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe Kidney Cancer Sales by Country (2021-2026) & (K Units) Table 145. Europe Kidney Cancer Sales Market Share by Country (2021-2026) Table 146. Europe Kidney Cancer Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe Kidney Cancer Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Kidney Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Kidney Cancer Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Kidney Cancer Market Share by Country (2021-2026) Table 151. Europe Kidney Cancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Kidney Cancer Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Kidney Cancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Kidney Cancer Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific Kidney Cancer Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Kidney Cancer Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific Kidney Cancer Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Kidney Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Kidney Cancer Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Kidney Cancer Market Share by Country (2021-2026) Table 161. Asia-Pacific Kidney Cancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Kidney Cancer Market Share Forecast by Country (2027-2032) Table 163. Latin America Kidney Cancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America Kidney Cancer Sales by Country (2021-2026) & (K Units) Table 165. Latin America Kidney Cancer Sales Market Share by Country (2021-2026) Table 166. Latin America Kidney Cancer Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America Kidney Cancer Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Kidney Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Kidney Cancer Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Kidney Cancer Market Share by Country (2021-2026) Table 171. Latin America Kidney Cancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Kidney Cancer Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Kidney Cancer Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Kidney Cancer Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa Kidney Cancer Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Kidney Cancer Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa Kidney Cancer Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Kidney Cancer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Kidney Cancer Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Kidney Cancer Market Share by Country (2021-2026) Table 181. Middle East and Africa Kidney Cancer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Kidney Cancer Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Kidney Cancer Distributors List Table 186. Kidney Cancer Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Kidney Cancer Image Figure 2. Global Kidney Cancer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Cancer Market Size (2021-2032) & (US$ Million) Figure 4. Global Kidney Cancer Sales (2021-2032) & (K Units) Figure 5. Targeted Therapy Image Figure 6. Global Targeted Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 7. Immunotherapy Image Figure 8. Global Immunotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Surgery Image Figure 10. Global Surgery Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Kidney Cancer Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Kidney Cancer Market Share by Type 2025 VS 2032 Figure 15. North America Kidney Cancer Sales Market Share in Volume by Type in 2025 Figure 16. North America Kidney Cancer Sales Market Share in Value by Type in 2025 Figure 17. Europe Kidney Cancer Sales Market Share in Volume by Type in 2025 Figure 18. Europe Kidney Cancer Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Kidney Cancer Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Kidney Cancer Sales Market Share in Value by Type in 2025 Figure 21. Latin America Kidney Cancer Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Kidney Cancer Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Kidney Cancer Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Kidney Cancer Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Kidney Cancer Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. 肾细胞癌（RCC） Image Figure 28. Global 肾细胞癌（RCC） Sales YoY Growth (2021-2032) & (K Units) Figure 29. 移行细胞癌（TCC） Image Figure 30. Global 移行细胞癌（TCC） Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Kidney Cancer Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Kidney Cancer Market Share by Application 2025 VS 2032 Figure 33. North America Kidney Cancer Sales Market Share in Volume by Application in 2025 Figure 34. North America Kidney Cancer Sales Market Share in Value by Application in 2025 Figure 35. Europe Kidney Cancer Sales Market Share in Volume by Application in 2025 Figure 36. Europe Kidney Cancer Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Kidney Cancer Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Kidney Cancer Sales Market Share in Value by Application in 2025 Figure 39. Latin America Kidney Cancer Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Kidney Cancer Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Kidney Cancer Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Kidney Cancer Sales Market Share in Value by Application in 2025 Figure 43. North America Kidney Cancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Kidney Cancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Kidney Cancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Kidney Cancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Kidney Cancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Kidney Cancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Kidney Cancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Kidney Cancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Kidney Cancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Kidney Cancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Kidney Cancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Kidney Cancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Kidney Cancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Kidney Cancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Kidney Cancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Kidney Cancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Kidney Cancer Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Kidney Cancer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Kidney Cancer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Kidney Cancer Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Kidney Cancer Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Kidney Cancer Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Therapy
  • Immunotherapy
  • Surgery
  • Other
Applications
  • 肾细胞癌（RCC）
  • 移行细胞癌（TCC）
Companies covered
  • Eisai
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • Bayer
  • Amgen
  • Sun Pharmaceutical
  • Hikma Pharmaceuticals
  • Exelixis
  • Bristol-Myers Squibb
  • Aveo Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kidney Cancer Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Kidney Cancer Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Kidney Cancer Market by Type
  6. 1.3.1 Targeted Therapy
  7. 1.3.2 Immunotherapy
  8. 1.3.3 Surgery
  9. 1.3.4 Other
  10. 1.4 Global Kidney Cancer Market Size by Type
  11. 1.4.1 Global Kidney Cancer Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Kidney Cancer Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Kidney Cancer Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Kidney Cancer Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Kidney Cancer Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Kidney Cancer Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Kidney Cancer Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Kidney Cancer Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Kidney Cancer Industry Trends
  2. 2.2 Kidney Cancer Industry Drivers
  3. 2.3 Kidney Cancer Industry Opportunities and Challenges
  4. 2.4 Kidney Cancer Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Kidney Cancer Revenue (2021-2026)
  2. 3.2 Global Top Players by Kidney Cancer Sales (2021-2026)
  3. 3.3 Global Top Players by Kidney Cancer Price (2021-2026)
  4. 3.4 Global Kidney Cancer Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kidney Cancer Major Company Production Sites & Headquarters
  6. 3.6 Global Kidney Cancer Company, Product Type & Application
  7. 3.7 Global Kidney Cancer Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kidney Cancer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kidney Cancer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kidney Cancer Tier 1, Tier 2, and Tier 3
4 Kidney Cancer Regional Status and Outlook
  1. 4.1 Global Kidney Cancer Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Kidney Cancer Historic Market Size by Region
  3. 4.2.1 Global Kidney Cancer Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Kidney Cancer Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Kidney Cancer Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Kidney Cancer Forecasted Market Size by Region
  7. 4.3.1 Global Kidney Cancer Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Kidney Cancer Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Kidney Cancer Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Kidney Cancer by Application
  1. 5.1 Kidney Cancer Market by Application
  2. 5.1.1 肾细胞癌（RCC）
  3. 5.1.2 移行细胞癌（TCC）
  4. 5.2 Global Kidney Cancer Market Size by Application
  5. 5.2.1 Global Kidney Cancer Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Kidney Cancer Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Kidney Cancer Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Kidney Cancer Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Kidney Cancer Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Kidney Cancer Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Kidney Cancer Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Kidney Cancer Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Kidney Cancer Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Kidney Cancer Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Kidney Cancer Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Kidney Cancer Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Kidney Cancer Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Kidney Cancer Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amgen Kidney Cancer Product Portfolio
  42. 6.7.5 Amgen Recent Developments
  43. 6.8 Sun Pharmaceutical
  44. 6.8.1 Sun Pharmaceutical Company Information
  45. 6.8.2 Sun Pharmaceutical Business Overview
  46. 6.8.3 Sun Pharmaceutical Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Kidney Cancer Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Recent Developments
  49. 6.9 Hikma Pharmaceuticals
  50. 6.9.1 Hikma Pharmaceuticals Company Information
  51. 6.9.2 Hikma Pharmaceuticals Business Overview
  52. 6.9.3 Hikma Pharmaceuticals Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hikma Pharmaceuticals Kidney Cancer Product Portfolio
  54. 6.9.5 Hikma Pharmaceuticals Recent Developments
  55. 6.10 Exelixis
  56. 6.10.1 Exelixis Company Information
  57. 6.10.2 Exelixis Business Overview
  58. 6.10.3 Exelixis Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Exelixis Kidney Cancer Product Portfolio
  60. 6.10.5 Exelixis Recent Developments
  61. 6.11 Bristol-Myers Squibb
  62. 6.11.1 Bristol-Myers Squibb Company Information
  63. 6.11.2 Bristol-Myers Squibb Business Overview
  64. 6.11.3 Bristol-Myers Squibb Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myers Squibb Kidney Cancer Product Portfolio
  66. 6.11.5 Bristol-Myers Squibb Recent Developments
  67. 6.12 Aveo Pharmaceuticals
  68. 6.12.1 Aveo Pharmaceuticals Company Information
  69. 6.12.2 Aveo Pharmaceuticals Business Overview
  70. 6.12.3 Aveo Pharmaceuticals Kidney Cancer Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Aveo Pharmaceuticals Kidney Cancer Product Portfolio
  72. 6.12.5 Aveo Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Kidney Cancer Sales by Country
  2. 7.1.1 North America Kidney Cancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Kidney Cancer Sales by Country (2021-2026)
  4. 7.1.3 North America Kidney Cancer Sales Forecast by Country (2027-2032)
  5. 7.2 North America Kidney Cancer Market Size by Country
  6. 7.2.1 North America Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Kidney Cancer Market Size by Country (2021-2026)
  8. 7.2.3 North America Kidney Cancer Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Kidney Cancer Sales by Country
  2. 8.1.1 Europe Kidney Cancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Kidney Cancer Sales by Country (2021-2026)
  4. 8.1.3 Europe Kidney Cancer Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Kidney Cancer Market Size by Country
  6. 8.2.1 Europe Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Kidney Cancer Market Size by Country (2021-2026)
  8. 8.2.3 Europe Kidney Cancer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Kidney Cancer Sales by Country
  2. 9.1.1 Asia-Pacific Kidney Cancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Kidney Cancer Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Kidney Cancer Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Kidney Cancer Market Size by Country
  6. 9.2.1 Asia-Pacific Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Kidney Cancer Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Kidney Cancer Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Kidney Cancer Sales by Country
  2. 10.1.1 South America Kidney Cancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Kidney Cancer Sales by Country (2021-2026)
  4. 10.1.3 South America Kidney Cancer Sales Forecast by Country (2027-2032)
  5. 10.2 South America Kidney Cancer Market Size by Country
  6. 10.2.1 South America Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Kidney Cancer Market Size by Country (2021-2026)
  8. 10.2.3 South America Kidney Cancer Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Kidney Cancer Sales by Country
  2. 11.1.1 Middle East and Africa Kidney Cancer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Kidney Cancer Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Kidney Cancer Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Kidney Cancer Market Size by Country
  6. 11.2.1 Middle East and Africa Kidney Cancer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Kidney Cancer Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Kidney Cancer Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Kidney Cancer Value Chain Analysis
  2. 12.1.1 Kidney Cancer Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Kidney Cancer Production Mode & Process
  7. 12.2 Kidney Cancer Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Kidney Cancer Distributors
  10. 12.2.3 Kidney Cancer Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst